REGISTER: Upcoming Workshops Patient Rights and Rare Diseases in the European Union

The European Commission is hosting workshops in several countries with a focus on patient rights in cross-border healthcare and European Reference Networks. There are 2 workshops in September and registration is now open:

17 September Athens covering Cyprus-Greece register now

26 September Valga/Valka covering Estonia-Latvia register now

9 October Warsaw, Poland register now

Upcoming other events

19 November Brussels covering Belgium-Netherlands

3 February 2025 Oradea covering Romania-Hungary

28 February, 2025 Strasbourg

 

Contact DG Sante for more information.

Continue reading

This entry was posted in General.

CONTRIBUTE: Cross-Border Access to Paediatric Clinical Trials Working Group (WG) survey

The Cross-Border Access to Paediatric Clinical Trials Working Group (WG) created by the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) is collecting data. The aim of this WG is to facilitate the inclusion of children and young people in clinical trials across Europe avoiding any language barriers. Recently we have identified that some patients could not take part in a clinical trial because they do not speak the official language of the country where the trial is performed or English.

Enpr-EMA is currently collecting data from Clinical Research Units and, also from parents of children living [...]

Continue reading

This entry was posted in General.

RESULTS: Screening Rare Disease at Birth

EURORDIS recently published the results of their full Rare Barometer survey which can be found here. The key findings are available in multiple languages.

Key findings include:

4.7 years for a confirmed diagnosis 40% have NOT been referred to a Centre of Expertise 25% had 8 consultations or more with healthcare professionals before their diagnosis was confirmed

EURORDIS also provided a breakdown of the responses related to rare endocrine conditions.

Continue reading

This entry was posted in General.

NEW GUIDELINE: Bardet-Biedl syndrome

Just published Bardet-Biedl syndrome improved diagnosis criteria and management: Inter European Reference Networks consensus statement and recommendations .

Four European Reference Networks (ERN-EYE, ERKNet, Endo-ERN, ERN-ITHACA) have teamed up to establish a consensus statement and recommendations for Bardet-Biedl syndrome (BBS) providing guidance for the relevant experts.

This consensus statement also emphasizes on initial diagnosis, monitoring and lifelong follow-up, and symptomatic care that can be provided to patients and family members according to the involved care professionals.”

The guideline is relevant for Endo-ERN MTGs 3, 5, 6.

Continue reading

This entry was posted in General.

ENGAGED: Endo-ERN ePAG Bernd Rosenbichler

Endo-ERN ePAG Bernd Rosenbichler shared a recent event organised by a local representative that featured his talented son Ben.

“Erich Irlstorfer, member of the German Bundestag, took up the topic of rare diseases almost 1.5 years ago – as a non-partisan initiative. He organized over 60 events with several thousand participants on the topic of Rare in Bavaria. He is in talks with European politicians to give the topic even more space. Other German states are following and also taking action. He brings his experiences and demands to the German Bundestag and to the political committees.

On July 13, he [...]

Continue reading

This entry was posted in General.

INFO: Transversal Working Group on GENOMIC testing in endocrine disorders

The Endo-ERN covers under its umbrella a broad range of endocrine disorders, and a significant number of these entities are caused by genetic variants. The underlying disorders are commonly rare and research, diagnostic testing and treatment are fragmented. Clinically, the disorders covered by Endo-ERN are heterogeneous, as are their genetic basis.

However, the genetic mechanisms behind the disorders as well as the genetic testing strategies are very similar. The last years have seen considerable improvement of genetic testing and – as a consequence – of the development and implementation of personalized treatment strategies.

 

The need to implement and run [...]

Continue reading

This entry was posted in General.

CRITERIA UPDATED: Young and newly diagnosed adults living with Addison’s disease

Walden University in Minneapolis, Minnesota, USA has a new study about the experiences of managing and living with autoimmune Addison’s disease in the younger and newly diagnosed adults. Researcher Mathew Horodner is seeking English speaking patients aged 18-30 for a video interview that will audio-recorded.

 

The criteria has been expanded and you may now qualify to particpate. Check out the new flyer or contact researcher Mathew Horodner.

 

 

Continue reading

This entry was posted in General.

PREPARE: CPMS 2.0 coming soon

The new CPMS 2.0 system went live 31 May, 2024.

For the next few months Endo-ERN will continue to use the original CPMS, as we start preparation for a network-wide migration to the new CPMS 2.0 system. Existing users will automatically have an account in the new system once data migration occurs, using their same login details for EU login. If you want to test the system ahead of our network’s formal migration, please contact our helpdesk.

With the new system comes formal steps for each of our member HCPs. The new system security documentation will be shared [...]

Continue reading

This entry was posted in General.